Nutex Health Statistics Share Statistics Nutex Health has 5.56M
shares outstanding. The number of shares has increased by 9.66%
in one year.
Shares Outstanding 5.56M Shares Change (YoY) 9.66% Shares Change (QoQ) 2.17% Owned by Institutions (%) 19.88% Shares Floating 3.54M Failed to Deliver (FTD) Shares 12,327 FTD / Avg. Volume 5.21%
Short Selling Information The latest short interest is 817.57K, so 14.69% of the outstanding
shares have been sold short.
Short Interest 817.57K Short % of Shares Out 14.69% Short % of Float 22.74% Short Ratio (days to cover) 2.35
Valuation Ratios The PE ratio is 3.1 and the forward
PE ratio is 7.43.
Nutex Health's PEG ratio is
-0.02.
PE Ratio 3.1 Forward PE 7.43 PS Ratio 0.34 Forward PS 0.6 PB Ratio 1.1 P/FCF Ratio 7.75 PEG Ratio -0.02
Financial Ratio History Enterprise Valuation Nutex Health has an Enterprise Value (EV) of 458.34M.
EV / Sales 0.95 EV / EBITDA 3.08 EV / EBIT 19.8 EV / FCF 21.98
Financial Position The company has a current ratio of 2.08,
with a Debt / Equity ratio of 2.33.
Current Ratio 2.08 Quick Ratio 2.06 Debt / Equity 2.33 Debt / EBITDA 2.29 Debt / FCF 16.32 Interest Coverage 6.55
Financial Efficiency Return on Equity is 35.65% and Return on Invested Capital is 20.91%.
Return on Equity 35.65% Return on Assets 7.96% Return on Invested Capital 20.91% Revenue Per Employee $599.94K Profits Per Employee $65.22K Employee Count 800 Asset Turnover 0.73 Inventory Turnover 99.55
Taxes Income Tax 14.48M Effective Tax Rate 13.19%
Stock Price Statistics The stock price has increased by 610.48% in the
last 52 weeks. The beta is 1.94, so Nutex Health's
price volatility has been higher than the market average.
Beta 1.94 52-Week Price Change 610.48% 50-Day Moving Average 115.05 200-Day Moving Average 76.94 Relative Strength Index (RSI) 38.12 Average Volume (20 Days) 236,645
Income Statement In the last 12 months, Nutex Health had revenue of 479.95M
and earned 52.18M
in profits. Earnings per share was 10.23.
Revenue 479.95M Gross Profit 196.26M Operating Income 130.62M Net Income 52.18M EBITDA 148.65M EBIT 129.68M Earnings Per Share (EPS) 10.23
Full Income Statement Balance Sheet The company has 43.58M in cash and 340.3M in
debt, giving a net cash position of -296.72M.
Cash & Cash Equivalents 43.58M Total Debt 340.3M Net Cash -296.72M Retained Earnings -356.89M Total Assets 761.92M Working Capital 224.95M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 23.15M
and capital expenditures -2.3M, giving a free cash flow of 20.85M.
Operating Cash Flow 23.15M Capital Expenditures -2.3M Free Cash Flow 20.85M FCF Per Share 4.09
Full Cash Flow Statement Margins Gross margin is 40.89%, with operating and profit margins of 27.22% and 10.87%.
Gross Margin 40.89% Operating Margin 27.22% Pretax Margin 22.87% Profit Margin 10.87% EBITDA Margin 30.97% EBIT Margin 27.22% FCF Margin 4.34%
Dividends & Yields NUTX does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield 32.29% FCF Yield 12.9%
Dividend Details Analyst Forecast The average price target for NUTX is $262.5,
which is 193.2% higher than the current price. The consensus rating is "Strong Buy".
Price Target $262.5 Price Target Difference 193.2% Analyst Consensus Strong Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value $51.15 Lynch Upside -42.86% Graham Number 81.27 Graham Upside -9.22%
Stock Splits The last stock split was on Jul 3, 2024. It was a
backward
split with a ratio of 1:10.
Last Split Date Jul 3, 2024 Split Type backward Split Ratio 1:10
Scores Altman Z-Score 1.99 Piotroski F-Score 7
